| 18.09 12:00 | dpa-AFX: GNW-Adhoc: Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference |
| 22.08 12:30 | dpa-AFX: GNW-Adhoc: Zymeworks Announces Participation in Upcoming Investor Conferences |
| 01.08 22:10 | dpa-AFX: GNW-Adhoc: Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock |
| 25.07 22:30 | dpa-AFX: GNW-Adhoc: Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer |
| 22.07 12:00 | dpa-AFX: GNW-Adhoc: Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-? Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate |
| 11.07 12:30 | dpa-AFX: GNW-Adhoc: Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024 |
| 17.06 12:00 | dpa-AFX: GNW-Adhoc: Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers |
| 10.06 12:00 | dpa-AFX: GNW-Adhoc: Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer |
| 28.05 12:30 | dpa-AFX: GNW-Adhoc: Zymeworks Announces Participation in Upcoming Investor Conferences |
| 02.05 22:05 | dpa-AFX: GNW-Adhoc: Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results |
| 30.04 12:00 | dpa-AFX: GNW-Adhoc: Zymeworks Announces Participation in Upcoming Investor Conferences |
| 08.04 12:00 | dpa-AFX: GNW-Adhoc: Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting |
| 28.03 11:00 | dpa-AFX: GNW-Adhoc: Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors |
| 27.03 11:00 | dpa-AFX: GNW-Adhoc: Zymeworks Announces Participation in Upcoming Investor Conferences |
| 05.03 22:30 | dpa-AFX: GNW-Adhoc: Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting |
| 27.02 12:00 | dpa-AFX: GNW-Adhoc: Zymeworks Announces Participation in Upcoming Investor Conferences |
| 08.02 12:00 | dpa-AFX: GNW-Adhoc: Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors |
| 31.01 12:00 | dpa-AFX: GNW-Adhoc: Zymeworks Announces Participation in Upcoming Investor Conferences |
| 04.01 12:15 | dpa-AFX: GNW-Adhoc: Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025 |
| 04.01 12:00 | dpa-AFX: GNW-Adhoc: Zymeworks Announces Additional Leadership Appointments |
|
|
